Case Study: Clinical basis of MHLW approval of Astellas’s Evrenzo to treat anemia of CKD in adult patients not on dialysis
Posted on28 Nov 2020
Comments0
Astellas Pharma Inc. and FibroGen, Inc. announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved Evrenzo (roxadustat) for the treatment... Read More
Covid 19 Vaccine development and commercialization status | More than 50 vaccine candidate under development
Posted on28 Nov 2020
Comments0
More than 50 covid-19 vaccine candidate is currently under development. Here you can have the close look into the development status of... Read More
PostEra codevelopment deal with NeuroLucent for Alzheimer’s disease
Posted on28 Nov 2020
Comments0
Biotechnology company PostEra announced a collaboration with NeuroLucent, a Chicago-based company focused on developing novel treatments for Alzheimer’s disease and other dementias.... Read More
AbbVie, Eisai received new indication approval for Humira to treat pyoderma gangrenosum
AbbVie GK and Eisai Co, Ltd announced an approval of additional indication of Humira, a fully human anti-TNFa monoclonal antibody, for the... Read More
Pfizer submitted application for emergency use of Covid vaccine
US drugmaker Pfizer Inc, which has developed a vaccine against coronavirus, is now seeking the emergency use tag from the US government... Read More
Take Self Competency Test in Esxport Documentation
You can take a short and quick competency test on pharmaceutical export.
Insight on VFMCRP, Fresenius Kabi distribution agreement for Veltassa to treat hyperkalemia in China
Posted on20 Nov 2020
Comments0
Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Fresenius Kabi announced an agreement to develop, register and distribute Veltassa for the treatment... Read More
US FDA grants priority review status to Sanofi’s BLA for avalglucosidase alfa to treat Pompe disease
The US Food and Drug Administration (FDA) has accepted for priority review the Biologics License Application (BLA) for avalglucosidase alfa for long-term... Read More